Oregon Health & Science University
Portland, Oregon, United States
Dr. Stauffer is Director of the Social Neuroscience & Psychotherapy Lab, Assistant Professor of Psychiatry at the Oregon Health & Science University (OHSU), and is dual board-certified in Psychiatry and Addiction Medicine. Dr. Stauffer’s research work aims to maximize the benefits of psychotherapy through the adjunct use of social psychopharmacology—such as oxytocin, MDMA, and psilocybin. Previous clinical trials include: oxytocin-enhanced motivational interviewing group therapy for methamphetamine-using men who have sex with men, Phase 2 and Phase 3 trials of MDMA-assisted psychotherapy for PTSD, and psilocybin-assisted group therapy for demoralization in long-term AIDS survivors. Ongoing studies include: psilocybin-assisted therapy for Veterans with methamphetamine use disorder and the first clinical trial of MDMA-assisted group therapy for PTSD. Dr. Stauffer serves as Supervisor for the MDMA Therapy Training Program at the Multidisciplinary Association for Psychedelic Studies, mentor for the Center for Psychedelic Therapies and Research certificate program at the California Institute of Integral Studies, core faculty for the Integrative Psychiatry Institute’s Psychedelic-Assisted Therapy Training, course contributor for Psychedelic.Support, and serves as member of the Oregon Governor's Psilocybin Advisory Board.
Sunday, August 7, 2022
8:30 AM – 9:30 AM